Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin
about
Pancreatic cancer surgery: past, present, and futureEarly detection of pancreatic cancerAntibodies to watch in 2015The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis.Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer.The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy.Biomarkers for early diagnosis of pancreatic cancer.Pancreatic cancer in chronic pancreatitis.A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.Ramifications of Secreted Mucin MUC5AC in Malignant Journey: A Holistic View.
P2860
Q26781555-7DB82815-1938-46E9-9BF7-1743642C2160Q26781558-9259274E-287A-463D-BBF9-3C88F1D691A6Q28253501-1AFE3823-F3FA-4CFB-B6C0-E3D4D9279A76Q33858586-5C19F111-0117-4831-90B2-00B98CFBDDA9Q35007556-2D478911-952B-45EA-A9E1-1D0AFD2466A8Q35551996-08C26F2E-46BC-4788-8843-BF87393F70A3Q37730714-B276A1DC-0235-40E0-9823-8ACB5F8E9D8CQ38265405-1F3F23F3-B402-4975-B6F0-BC17D454014EQ38971873-7192DE9F-8427-4D72-BD84-F084EB647A0BQ41985946-BA777F42-6731-4CAF-B2BB-23EC400BCC98Q50133047-E2A9BC54-D177-4470-B576-642CD2EDACC3
P2860
Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mapping PAM4 (clivatuzumab), a ...... denocarcinoma, to MUC5AC mucin
@ast
Mapping PAM4 (clivatuzumab), a ...... denocarcinoma, to MUC5AC mucin
@en
Mapping PAM4 (clivatuzumab), a ...... enocarcinoma, to MUC5AC mucin.
@nl
type
label
Mapping PAM4 (clivatuzumab), a ...... denocarcinoma, to MUC5AC mucin
@ast
Mapping PAM4 (clivatuzumab), a ...... denocarcinoma, to MUC5AC mucin
@en
Mapping PAM4 (clivatuzumab), a ...... enocarcinoma, to MUC5AC mucin.
@nl
prefLabel
Mapping PAM4 (clivatuzumab), a ...... denocarcinoma, to MUC5AC mucin
@ast
Mapping PAM4 (clivatuzumab), a ...... denocarcinoma, to MUC5AC mucin
@en
Mapping PAM4 (clivatuzumab), a ...... enocarcinoma, to MUC5AC mucin.
@nl
P2093
P2860
P356
P1433
P1476
Mapping PAM4 (clivatuzumab), a ...... denocarcinoma, to MUC5AC mucin
@en
P2093
David M Goldenberg
David V Gold
Donglin Liu
Guy Newsome
P2860
P2888
P356
10.1186/1476-4598-12-143
P577
2013-11-20T00:00:00Z
P5875
P6179
1021320357